Literature DB >> 12011783

Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy.

Michel Noutsias1, Matthias Pauschinger, Karsten Ostermann, Felicitas Escher, Jan-Henrik Blohm, Heinz Schultheiss, Uwe Kühl.   

Abstract

BACKGROUND: We attempted to develop a digital image analysis (DIA) system for endomyocardial biopsies (EMBs) to reliably quantify a) biopsy quality, b) immunohistochemically-marked infiltrates, and c) cell adhesion molecules (CAMs) in relation to net heart area (HA) for the semi-automated diagnosis of inflammatory cardiomyopathy (InfCM). MATERIAL/
METHODS: 140 EMBs from dilated cardiomyopathy (DCM) patients and 14 autopsy heart samples (controls) were immunostained for T-lymphocytes (CD2, CD3, CD4, CD8), beta(2)-integrin+ infiltrates (CD18, LFA-1, Mac-1) and CAMs (immunoglobulin superfamily: ICAM-1, HLA class I, HLA DR, VCAM-1, CD58; selectins: CD62E and CD62P; and the beta(1)-integrin chain CD29). EMB quality was assessed visually on a three-point scale. Infiltrates were quantified visually (per hpf) and by DIA (per mm2 HA). CAM expression was evaluated semiquantitatively and by DIA (area fraction [AF]: stained area relative to HA).
RESULTS: DIA-evaluated HA correlated significantly with the visual assessment of EMB quality. The visual evaluation of both infiltrates and CAMs correlated significantly with the respective DIA-based quantification. DIA-quantified CAM-AF and infiltrates were discriminated by the CAM classification (CAMs+: n=87; 62%) compared to controls. DIA-quantified CAM immunoreactivity correlated significantly with the DIA-quantified counter-receptor+ infiltrates. DIA evaluation of biopsy quality, infiltrates, and CAMs was devoid of inter- and intraobserver variability.
CONCLUSIONS: The DIA system presented here enables standardized and observer-independent assessment of EMB quality and intramyocardial inflammation (density of infiltrates and CAM expression) in DCM biopsies related to HA. Our data confirm that endothelial CAM count and counter-receptor+ immunocompetent infiltration are interdependent pathogenic and diagnostic hallmarks of InfCM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011783

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  15 in total

1.  Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.

Authors:  Hong-Tao Wang; Shuang Chen; Jie Wang; Qing-Jia Ou; Chao Liu; Shu-Sen Zheng; Mei-Hai Deng; Xiao-Ping Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy.

Authors:  Markus Grube; Sabine Ameling; Michel Noutsias; Kathleen Köck; Ivonne Triebel; Karina Bonitz; Konrad Meissner; Gabriele Jedlitschky; Lars R Herda; Markus Reinthaler; Maria Rohde; Wolfgang Hoffmann; Uwe Kühl; Heinz-Peter Schultheiss; Uwe Völker; Stephan B Felix; Karin Klingel; Reinhard Kandolf; Heyo K Kroemer
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Biomarkers in inflammatory and noninflammatory cardiomyopathy.

Authors:  Michel Noutsias; Sabine Pankuweit; Bernhard Maisch
Journal:  Herz       Date:  2009-12       Impact factor: 1.443

Review 4.  Myocarditis: early biopsy allows for tailored regenerative treatment.

Authors:  Uwe Kühl; Heinz-Peter Schultheiss
Journal:  Dtsch Arztebl Int       Date:  2012-05-18       Impact factor: 5.594

5.  Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.

Authors:  Trynda N Kroneman; Jesse S Voss; Christine M Lohse; Tsung-Teh Wu; Thomas C Smyrk; Lizhi Zhang
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

Review 6.  Meta-analysis on the immunohistological detection of inflammatory cardiomyopathy in endomyocardial biopsies.

Authors:  Julius L Katzmann; Peter Schlattmann; Angelos G Rigopoulos; Ewa Noutsias; Boris Bigalke; Matthias Pauschinger; Carsten Tschope; Daniel Sedding; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

Review 7.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 8.  Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

Authors:  M Pauschinger; M Noutsias; D Lassner; H-P Schultheiss; U Kuehl
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

9.  Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.

Authors:  Pirus Ghadjar; Christoph Loddenkemper; Sarah Ellen Coupland; Andrea Stroux; Michel Noutsias; Eckhard Thiel; Frank Christoph; Kurt Miller; Carmen Scheibenbogen; Ulrich Keilholz
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-09       Impact factor: 4.553

10.  Cellular immune mechanisms in myocarditis.

Authors:  M Noutsias; V J Patil; B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.